Literature DB >> 16652276

Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus.

Binh An Diep1, Heather A Carleton, Richard F Chang, George F Sensabaugh, Francoise Perdreau-Remington.   

Abstract

BACKGROUND: The extent to which the horizontal transfer of virulence genes has contributed to the emergence of contemporary virulent strains of methicillin-resistant Staphylococcus aureus (MRSA) in hospital and community settings is poorly understood.
METHODS: Epidemiologically well-characterized MRSA isolates collected over 8.5 years were genotyped and tested for the presence of 34 virulence genes.
RESULTS: Six strain types accounted for 88.2% of all MRSA infections. The evolution of contemporary hospital and community phenotypes within the CC8 and CC30 lineages--2 background genomes that produced historical pandemic MRSA clones--were associated with multiple horizontal acquisitions of virulence genes. The epidemic community phenotype of a CC8 strain, designated ST8:USA300, was linked to the acquisition of staphylococcal cassette chromosome (SCC)mec type IV, the genes for Panton-Valentine leukocidin (PVL), and the enterotoxin Q and K genes. Similarly, the epidemic community phenotype of a CC30 strain, ST30:USA1100, was linked to the acquisition of SCCmec type IV and the pvl genes. In contrast, the epidemic hospital phenotype of another CC30 strain, ST36:USA200, was associated with the acquisition of SCCmec type II, the enterotoxin A gene, and the toxic shock syndrome toxin 1 gene. The pvl genes appear not to be essential for the evolution OF other community-associated strains of mrsa, including ST8:USA500 and ST59:USA1000.
CONCLUSIONS: The horizontal transfer of virulence genes, although infrequent, is epidemiologically associated with the emergence of new virulent strains of MRSA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16652276     DOI: 10.1086/503777

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  115 in total

1.  Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo.

Authors:  Francis Alonzo; Meredith A Benson; John Chen; Richard P Novick; Bo Shopsin; Victor J Torres
Journal:  Mol Microbiol       Date:  2011-12-20       Impact factor: 3.501

2.  EsaD, a secretion factor for the Ess pathway in Staphylococcus aureus.

Authors:  Mark Anderson; Yi-Hsing Chen; Emily K Butler; Dominique M Missiakas
Journal:  J Bacteriol       Date:  2011-01-28       Impact factor: 3.490

Review 3.  Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).

Authors:  Lance R Thurlow; Gauri S Joshi; Anthony R Richardson
Journal:  FEMS Immunol Med Microbiol       Date:  2012-03-05

4.  Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates.

Authors:  Kati Seidl; Arnold S Bayer; Vance G Fowler; James A McKinnell; Wessam Abdel Hady; George Sakoulas; Michael R Yeaman; Yan Q Xiong
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

5.  Keratinocytes produce IL-6 in response to desmoglein 1 cleavage by Staphylococcus aureus exfoliative toxin A.

Authors:  Cleo E Rolle; Juan Chen; Irena Pastar; Tatiana C P Cardenas; Roberto Perez; Suzanne Hower; Franco Ferracci; Richard Snyder; Marjana Tomic-Canic; Lisa R W Plano
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

6.  Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  Jörg J Ruhe; Anupama Menon
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

7.  Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center.

Authors:  Roopa Ganga; Kathleen Riederer; Mamta Sharma; Mohamad G Fakih; Leonard B Johnson; Stephen Shemes; Riad Khatib
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

8.  Staphylococcus aureus beta-toxin induces lung injury through syndecan-1.

Authors:  Atsuko Hayashida; Allison H Bartlett; Timothy J Foster; Pyong Woo Park
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

9.  Detection and measurement of staphylococcal enterotoxin-like K (SEl-K) secretion by Staphylococcus aureus clinical isolates.

Authors:  Jorge L Aguilar; Avanish K Varshney; Xiaobo Wang; Lindsay Stanford; Matthew Scharff; Bettina C Fries
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

10.  Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia.

Authors:  Binh An Diep; Anna Afasizheva; Hoan N Le; Osamu Kajikawa; Gustavo Matute-Bello; Christine Tkaczyk; Bret Sellman; Cedric Badiou; Gerard Lina; Henry F Chambers
Journal:  J Infect Dis       Date:  2013-03-26       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.